Rochelle Seide
Corporate Officer/Principal chez Biovail Laboratories International SRL
Provenance du réseau au premier degré de Rochelle Seide
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Biovail Laboratories International SRL
 Biovail Laboratories International SRL Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Biovail Laboratories International SRL develops, manufactures, and sells pharmaceutical products. The company is based in Saint Michael, Barbados.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rochelle Seide via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of British Columbia | College/University | Corporate Officer/Principal | |
| University of Manitoba | College/University | Undergraduate Degree | |
AiVita Biomedical, Inc.
 AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Princeton University | College/University | Doctorate Degree | |
| University of Victoria | College/University | Undergraduate Degree | |
| University of Oxford | College/University | Graduate Degree |
Statistiques
Internationale
| Canada | 12 |
| Etats-Unis | 8 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 15 |
| Consumer Services | 6 |
Opérationnelle
| Director/Board Member | 9 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 2 |
| Chief Operating Officer | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Rochelle Seide
- Connexions Sociétés
